These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 29789890

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G, Lafforgue MP, Lion-François L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y, NF France network.
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [Abstract] [Full Text] [Related]

  • 5. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C, Aharoni S, Halevy A.
    Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
    [Abstract] [Full Text] [Related]

  • 6. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma.
    Eid H, Crevier-Sorbo G, Aldraihem A, Menegotto F, Wilson N.
    AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560
    [Abstract] [Full Text] [Related]

  • 7. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
    Farmer JP, Khan S, Khan A, Ortenberg J, Freeman C, O'Gorman AM, Montes J.
    Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma - a retrospective Magnetic Resonance Imaging study.
    Kilian A, Aigner A, Simon M, Salchow DJ, Potratz C, Thomale UW, Hernáiz Driever P, Tietze A.
    J Neurooncol; 2022 Feb; 156(3):589-597. PubMed ID: 34994964
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups.
    Tosun M, Güngör M, Uslu H, Anık Y.
    Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715
    [Abstract] [Full Text] [Related]

  • 13. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE, Nuding MA.
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [Abstract] [Full Text] [Related]

  • 14. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E, Jóźwiak S, Roszkowski M, Schwartz RA.
    J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652
    [Abstract] [Full Text] [Related]

  • 15. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Biggs E, Alsharid MA, Packer RJ, Linguraru MG.
    Neurology; 2016 Jun 14; 86(24):2264-70. PubMed ID: 27170570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.